Three-dimensional Co-culture Model for Tumor-stromal Interaction
17.3K Views
•
08:39 min
•
February 2nd, 2015
DOI :
February 2nd, 2015
•1Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, 2Department of Clinical Laboratory, Graduate School of Medicine, The University of Tokyo, 3Division for Health Service Promotion, The University of Tokyo, 4Department of Biochemistry, Nihon University School of Dentistry, 5Department of Biochemistry, Ohu University School of Pharmaceutical Sciences
Chapters in this video
0:05
Title
1:51
Primary Culture of Human Lung Fibroblasts
3:35
Three-dimensional Co-culture of Human Lung Fibroblasts and Cancer Cells
6:27
Air-liquid Interface Culture and Invasion Assay
7:14
Results: Analysis of A549 Cells Co-cultured on a 3D Collagen Gel Embedded with Primary Cultures of Cancer-associated Fibroblasts
8:09
Conclusion
Related Videos
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
7.1K Views
07:20
A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
9.8K Views
07:44
Monitoring Cancer Cell Invasion and T-Cell Cytotoxicity in 3D Culture
11.4K Views
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
5.1K Views
07:48
Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells
20.7K Views
08:16
Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
10.6K Views
07:43
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
278 Views
09:23
Three-Dimensional Culture Assay to Explore Cancer Cell Invasiveness and Satellite Tumor Formation
10.4K Views
07:27
Isolation of Mammary Epithelial Cells from Three-dimensional Mixed-cell Spheroid Co-culture
16.1K Views
03:36
3D Co-culture of Lung Cancer Cells with CAFs: An In Vitro Model System to Study Tumor Progression
2.3K Views
Copyright © 2025 MyJoVE Corporation. All rights reserved